Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
6.25
-0.10 (-1.57%)
At close: Mar 24, 2026, 4:00 PM EDT
6.36
+0.11 (1.76%)
After-hours: Mar 24, 2026, 7:27 PM EDT
Certara Employees
As of December 31, 2025, Certara had 1,576 total employees, including 1,515 full-time and 61 part-time employees. The number of employees increased by 30 or 1.94% compared to the previous year.
Employees
1,576
Change (1Y)
30
Growth (1Y)
1.94%
Revenue / Employee
$265,760
Profits / Employee
-$1,012
Market Cap
994.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,576 | 30 | 1.94% | 1,515 | 61 |
| Dec 31, 2024 | 1,546 | 155 | 11.14% | 1,487 | 59 |
| Dec 31, 2023 | 1,391 | 187 | 15.53% | 1,338 | 53 |
| Dec 31, 2022 | 1,204 | 90 | 8.08% | 1,150 | 54 |
| Dec 31, 2021 | 1,114 | 211 | 23.37% | 1,054 | 60 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teladoc Health | 5,600 |
| Omnicell | 3,580 |
| Phreesia | 2,082 |
| 10x Genomics | 1,178 |
| HealthStream | 1,160 |
| Omada Health | 916 |
| Schrödinger | 850 |
| HeartFlow | 699 |
CERT News
- 14 days ago - Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 15 days ago - Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript - Seeking Alpha
- 21 days ago - Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 21 days ago - Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - GlobeNewsWire
- 22 days ago - Touchstone Small Cap Fund Q4 2025 Portfolio Review - Seeking Alpha
- 25 days ago - Certara to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 26 days ago - Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance - GlobeNewsWire